Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome

Abstract

The number of genetic variations in the SARS-CoV-2 genome has been increasing primarily due to continuous viral mutations. Here, we report that the human APOBEC3A (A3A) cytidine deaminase plays a critical role in the induction of C-to-U substitutions in the SARS-CoV-2 genome. Bioinformatic analysis of the chronological genetic changes in a sequence database indicated that the largest UC-to-UU mutation signature, consistent with APOBEC-recognized nucleotide motifs, was predominant in single-stranded RNA regions of the viral genome. In SARS-CoV-2-infected cells, exogenous expression of A3A but not expression of other APOBEC proteins induced UC-to-UU mutations in viral RNA (vRNA). Additionally, the mutated C bases were often located at the tips in bulge or loop regions in the vRNA secondary structure. Interestingly, A3A mRNA expression was drastically increased by interferons (IFNs) and tumour necrosis factor-α (TNF-α) in epithelial cells derived from the respiratory system, a site of efficient SARS-CoV-2 replication. Moreover, the UC-to-UU mutation rate was increased in SARS-CoV-2 produced from lung epithelial cells treated with IFN-ß and TNF-α, but not from CRISPR/Cas9-based A3A knockout cells. Collectively, these findings demonstrate that A3A is a primary host factor that drives mutations in the SARS-CoV-2 RNA genome via RNA editing.

Human DNA tumor viruses evade uracil-mediated antiviral immunity

“…Most DTV’s establish persistence in the human host and AID/A3 proteins have not effectively achieved uracil-mediated antiviral immunity and instead are potentially being utilized by DTVs to evolve and promote immune escape. Notably, there are several recent studies suggesting that the A3 proteins are promoting the evolution and viral fitness of SARS-CoV-2 [ 52 , 53 ]. Even more dangerous is the threat to the host genome, which could promote cellular transformation and cancer.…”

Resistance‐associated mutations to the anti‐SARS‐CoV‐2 agent nirmatrelvir: Selection not induction

“…These could be signatures of the well-known APOBEC3 cellular enzymes. 36 As a matter of fact, these enzymes have been reported to edit the SARS-CoV-2 RNA, [37][38][39] and we have previously reported that APOBEC3 was associated with approximately one quarter of all the mutations harbored by 61 397 SARS-CoV-2 consensus genomes obtained in our laboratory. 13 Beyond, although described as involved in a host defense mechanism for the case of their targeting of HIV F I G U R E 1 Structural analysis of the impact of the E166V mutation on protease structure and nirmatrelvir binding.…”

BNT162b2 mRNA vaccine-induced sex differences in the single-cell transcriptome of peripheral blood mononuclear cells in healthy adults

“…We report that C8 cells also expressed high levels of APOBEC3A , which promotes replication, propagation, and evolution of SARS-CoV-2. 20, 21 In men, C8 cells displaced classical monocytes on Day 22 and mostly disappeared by Day 28, whereas they remained abundant in females through Day 28. The importance of C8 cells in vaccine-induced immunity and/or AEs remains to be fully elucidated.…”